Clinical Trial Update: Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating hypoxia-inducible factor prolyl hydroxylase inhibitors for sarcopenia and anemia in patients undergoing hemodialysis. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Sarcopenia

Drugs mentioned

• Hypoxia-inducible factor prolyl hydroxylase inhibitors

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD) | Phase 4 | Status: NOT_YET_RECRUITING